Get a Quote
Skip to main content

Praziquantel Protoscolex Assay: Dose Response and Damage

Praziquantel protoscolex testing in a cattle-derived Echinococcus granulosus assay showed concentration-dependent motility loss with a 24-hour IC50 of 0.364 micromolar and an LC50 of 2.51 millimolar. Viability fell more slowly than movement, and the drug damaged the tegument at 10^-4 M. These results separate paralysis from killing and give a direct read on how this molecule acts on larval tapeworm tissue.

What the praziquantel protoscolex assay measured

This was an in vitro pharmacology experiment on larval tapeworm tissue. The study asked one question: how does praziquantel change the movement and survival of protoscoleces during a fixed exposure window. Protoscoleces, or PSCs, are the larval heads found inside hydatid cysts. They carry suckers, a rostellum with hooks, and a living surface layer called the tegument. Every one of those structures can be scored under a microscope.

The design tested five compounds in two mechanistic classes. One class acts on ion channels and holds praziquantel, amlodipine, and amiloride. The other class acts on the cytoskeleton and holds albendazole and cytochalasin D. Because the study directly applied the anchor drug to the parasite, these data can be read as a compound-level result rather than an analogy. Two outcomes were tracked in parallel. Motility captured whether the larva still moved. Viability captured whether the larva still excluded dye and kept its shape. Tracking both matters because a worm can stop moving without dying, and a drug that only paralyzes may behave very differently from one that kills. The praziquantel protoscolex readouts were collected after a single 24-hour exposure and, in a separate arm, after a washout period.

Parasite material and culture conditions

Protoscoleces of Echinococcus granulosus sensu lato were extracted under sterile conditions from intact cysts in naturally infected cattle lungs. Intact cysts limit dissection damage and give a more uniform starting population. The parasite material was placed in DMEM supplemented with 0.4 percent (w/v) glucose. The medium also carried 100 IU per milliliter penicillin and 100 microgram per milliliter streptomycin to hold back bacterial growth.

Cultures were kept at 37 C in a humidified atmosphere containing 5 percent CO2. Protoscoleces rested at least 24 hours before any compound was added. The rest lets the tissue settle after isolation and gives imaging a stable baseline. Plates were sterile 96-well flat-bottom formats, with 50 to 60 protoscoleces placed in each well. Using a narrow count per well keeps image analysis tractable and reduces overlap between animals during the motility read.

The choice of a cattle source is worth noting for interpretation. The parasite was recovered from a natural infection rather than a laboratory passage, so the tissue reflects a real host environment. No ethical approval was required because the work was an in vitro parasite assay rather than a study in animals. Every subsequent number in this article traces to that single experimental setup.

Compound panel and exposure design

Five agents were tested across a concentration range from 10^-10 M to 10^-2 M. Exposure lasted 24 hours. The panel was split by mechanism. The ion-channel group contained praziquantel, listed as PZQ, amlodipine, listed as AML, and amiloride, listed as AMI. The cytoskeletal group contained albendazole, listed as ABZ, and cytochalasin D, listed as CD.

Using two classes on the same plates allows a direct comparison of how different mechanisms shape the same two outcomes. Ion-channel agents tend to act on membrane excitability and ion flux. Cytoskeletal modulators act on structural elements inside the cell. Praziquantel sits in the first group, so its effects are framed against both its own class and the cytoskeletal comparators. Concentration-response curves came from three independent experiments performed in duplicate. Solvent controls received the vehicle alone, and untreated controls received no addition. Duplicate wells within each run and three separate runs give enough points to fit curves and to test whether a simple model holds. The ten-order-of-magnitude range let the team follow each compound from no visible effect to its maximal response.

Motility and viability readouts

Motility was measured from images. Two sequential pictures were taken 10 seconds apart at 40x magnification. Pixel-based displacement was quantified in ImageJ, and the motility index was expressed as the percent movement relative to the DMSO control. A well with full movement would read near 100 percent of control, while a fully immobilized well would read near zero. This method scores function and not structure.

Viability used dye exclusion. Protoscoleces were exposed to 0.1 percent methylene blue for 5 minutes at room temperature and viewed at 40x. A larva counted as viable if it excluded the dye and kept normal morphology. Pairing dye exclusion with shape assessment avoids calling a damaged but unstained larva fully healthy. The viability read therefore carries both a membrane-integrity and a structural criterion.

For ultrastructure, samples were fixed in Karnovsky fixative made of 2.66 percent (w/v) paraformaldehyde and 1.66 percent (w/v) glutaraldehyde. They were then passed through graded ethanol at 50, 70, 90, and 100 percent, critical-point dried, and gold sputtered before viewing. Scanning electron microscopy gave a surface-level view of the tegument, suckers, rostellum, and hooks. Together the three readouts cover movement, survival, and surface damage in the same praziquantel protoscolex preparation.

Dose-response parameters across five compounds

Every compound was fitted with a four-parameter logistic model, with the top constrained to 100 percent. Absolute IC50 and LC50 values were solved at 50 percent response rather than read from a curve midpoint. The summary below gives motility IC50 in micromolar with 95 percent intervals, maximal motility effect in percent, viability LC50 in millimolar with intervals, maximal viability effect, and the R2 for each fit.

Compound

Motility IC50 uM [95% CI]

Motility Emax %

Motility R2

Viability LC50 mM [95% CI]

Viability Emax %

Viability R2

Albendazole

0.428 [0.133-1.33]

96.8 +/- 2.4

0.74

2.87 [1.23-n.d.] (extrapolated)

44.1 +/- 1.0

0.96

Cytochalasin D

0.0295 [0.00369-0.157]

94.4 +/- 4.0

0.55

0.405 [0.257-0.679]

57.7 +/- 3.8

0.96

Praziquantel

0.364 [0.0826-1.31]

99.2 +/- 0.3

0.69

2.51 [1.91-3.30]

83.4 +/- 2.6

0.97

Amlodipine

0.0207 [0.00866-0.0549]

100.0 +/- 0.0

0.78

0.627 [0.332-1.16]

100.0 +/- 0.0

0.91

Amiloride

39.7 [13.8-114]

94.3 +/- 1.9

0.73

7.84 [3.25-8.44]

91.9 +/- 3.0

0.98

Its IC50 of 0.364 micromolar placed it close to albendazole on motility but far from it on viability. Albendazole maximal viability loss was only 44.1 percent, whereas praziquantel reached 83.4 percent. That contrast is one reason to report both endpoints rather than one. Note on the table values: n.d. means not determined, and the albendazole upper interval was not constrained by the data, so its LC50 is marked extrapolated. For every compound the lethal concentration sat beyond the concentration needed to stop movement. For praziquantel the LC50 of 2.51 millimolar exceeded the motility IC50 of 0.364 micromolar by well over two orders of magnitude.

Curve shape and model fit

All five compounds inhibited motility in a concentration-dependent way. Yet the shapes were not all simple. Praziquantel and cytochalasin D dropped to an intermediate motility level and stayed there across several orders of magnitude before declining again at the highest concentrations. A single sigmoidal curve cannot follow that pattern, because it expects one smooth transition from top to bottom.

Hill slopes from the four-parameter logistic fits ranged from -0.15 to -0.37, and no 95 percent interval reached -1. A value of -1 would be expected for a single-site saturable process, so the shallow slopes argue against one clean binding site. The four-parameter model also explained less variance in motility, with R2 from 0.55 to 0.78, than in viability, where R2 ran from 0.91 to 0.98.

A lack-of-fit test against pure error found the four-parameter model inadequate only for praziquantel, with F(7,36) = 5.40 and p = 0.0003, and for cytochalasin D, with F(7,37) = 7.19 and p = 1.9 x 10^-5. A two-component model was preferred for praziquantel, cytochalasin D, and amlodipine, with delta AICc values of -12.1, -24.1, and -4.6. It was indistinguishable for amiloride at +0.2 and the single-component model was preferred for albendazole at +11.6. For praziquantel the two-component model improved the fit but still left significant lack of fit at p = 0.02.

The intermediate plateau sat near 50 percent of control, which is why the reported IC50 shifts with the chosen model. The dose-response table reports four-parameter values throughout so that all five compounds are compared on the same basis. Readers should treat those IC50 numbers as model-dependent summaries of a complex curve rather than as single precise thresholds.

Motility inhibition versus viability loss

To ask whether paralysis tracked death, the analysis used the mean of each compound-concentration combination as the unit, giving n = 39. Praziquantel, amlodipine, and albendazole each showed a significant inverse association between motility inhibition and viability. Cytochalasin D and amiloride did not. In plain terms, for three of the five agents a greater drop in movement went with a greater drop in survival.

Spearman rank correlations quantify that link. The table below lists the corrected coefficients, intervals, and p values for each treatment.

Treatment

rs

95% CI

p

Albendazole

-0.89

[-1.00, -0.40]

0.037

Cytochalasin D

-0.55

[-1.00, 0.34]

0.342

Praziquantel

-0.98

[-1.00, -0.79]

0.002

Amlodipine

-0.88

[-1.00, -0.32]

0.029

Amiloride

0.29

[-0.59, 1.00]

0.501

The praziquantel protoscolex pairs gave the strongest inverse coefficient at -0.98 with p = 0.002. Partial correlation weakened the picture. Adjusting for log10[dose] gave rs = -0.29 with a 95 percent interval of -0.62 to 0.16, which was not significant. Adding compound identity as a second control gave rs = 0.07 with an interval of -0.37 to 0.49, also not significant. Dose and drug choice therefore explain much of the apparent link when all compounds are pooled.

Segmented regression found breakpoints. For ion-channel agents the breakpoint was 75.1 percent motility inhibition, with a 95 percent interval of 71.5 to 82.4 and p < 0.001. Slopes were -0.06 and -3.88 percent viability per unit inhibition below and above that point. For cytoskeletal modulators the breakpoint was 54.0 percent, interval 46.6 to 91.8 and p = 0.019, with slopes of -0.14 and -1.02. Pooled segmented models covered n = 24 ion-channel points and n = 15 cytoskeletal points, and both improved over a straight line, at p < 0.001 and p = 0.019.

Washout and reversibility

Reversibility was tested by washing protoscoleces after the 24-hour exposure and then keeping them 24 hours in drug-free medium. If a compound only paralyzed the larvae, motility should have returned after removal. Five compound-concentration combinations were excluded because mean post-washout viability fell below 15 percent, which made the motility readout unreliable.

No compound showed a consistent or statistically supported recovery of motility after washout. Only albendazole showed significant dose dependence in the change in motility, and the sign pointed away from recovery: higher concentration meant a further decline after the drug was removed. At 10^-4 M, praziquantel, albendazole, and cytochalasin D each produced a change near zero, with post-washout viability between 78 and 95 percent. Those larvae excluded methylene blue but stayed immobile.

The result matters for how this effect is described. A near-zero change in motility after washout, together with high dye exclusion, points to a condition that is neither full death nor full recovery.

Tegument damage under scanning electron microscopy

Scanning electron microscopy showed distinct surface patterns for each agent. Controls kept a preserved rostellum, suckers, and body, with a continuous tegument densely covered by uniformly distributed microtrichia. Albendazole produced moderate damage, with partial distortion of body and suckers, an irregular surface, a disorganized tegument, and microtrichia lost over part of their extent. Cytochalasin D gave a severe phenotype, with suckers and body deformed and collapsed, tegument extensively disrupted, and microtrichia lost, shortened, or disorganized, leaving a surface that was often corrugated and eroded.

Praziquantel produced the most severe damage among the ion-channel modulators. The tegument collapsed and often exposed the underlying syncytial layer. The rostellar pad was distorted, hooks were displaced or embedded in folded tegument, and microtrichia were truncated or absent. In these praziquantel protoscolex specimens the surface injury was structural, not just a change in movement speed.

Amlodipine caused strong body contraction, thick tegumental folds, and vesicle-like structures especially around the suckers. Its surface was disorganized with detached debris, and microtrichia were sparse, shortened, or irregular. Amiloride gave the mildest lesions of the whole panel. Ordered by visible surface damage, the ion-channel agents ran from amiloride mildest, through amlodipine, to praziquantel most severe, with the cytoskeletal drug cytochalasin D also producing a severe collapsed appearance.

How the findings fit together

Three patterns run through the data. First, lethal concentrations exceeded motility-inhibiting concentrations by more than two orders of magnitude for every compound. Movement stops long before the population is wiped out. Second, maximal observed viability loss differed by agent: amlodipine reached 100.0 percent, amiloride 91.9 percent, and praziquantel 83.4 percent, with the cytoskeletal modulators landing further below complete killing. Third, the albendazole curve never crossed 50 percent lethality anywhere in the tested range.

Put together, the praziquantel protoscolex result is one of strong paralysis, intermediate killing, marked surface damage, and no clear reversal after washout. It sits between amlodipine, which killed more completely, and albendazole, which paralyzed at similar concentrations but killed far less. Cytochalasin D matched praziquantel on curve shape and ultrastructure while differing in its correlation profile.

These are concentration-response observations from a single 24-hour window on tissue taken from cattle lungs. They show what the molecule did to the parasite under the defined plate conditions. They do not by themselves describe absorption, distribution, or outcome in a whole animal, and the numbers should be read within that frame.

Practical implications for antiparasitic screening

For someone designing a screening cascade, the main lesson is to measure more than one endpoint. If only motility had been scored, praziquantel and albendazole would look nearly interchangeable on potency, with IC50 values of 0.364 and 0.428 micromolar. Adding viability separates them sharply, at 83.4 versus 44.1 percent maximal loss. A screen that records both movement and dye exclusion gains information that either read loses alone.

Curve shape deserves the same attention as the IC50 number. The intermediate plateau shown by praziquantel and cytochalasin D means a single log-logistic fit understates what is happening, as the lack-of-fit tests show. Reporting the model, the Hill slope, and the AICc comparison alongside the potency value would make the data easier to compare across compounds. Two-component behavior may signal more than one target or a transition between states.

Washout data add a further layer. A compound that leaves larvae immobile but dye-excluding after drug removal occupies an ambiguous zone. Deciding whether that counts as success depends on the goal of the screen. For routine work of this kind, pairing the acute 24-hour read with a drug-free follow-up would help distinguish durable effects from temporary ones.

Bottom line

The direct test of the anchor drug on larval tapeworm tissue produced a clear picture. Praziquantel protoscolex motility fell with a 24-hour IC50 of 0.364 micromolar and a maximal effect of 99.2 percent, while viability declined with an LC50 of 2.51 millimolar and a maximal loss of 83.4 percent. The curve carried an intermediate plateau that a single sigmoidal model could not follow, and the surface showed collapsed tegument, distorted rostellar pads, and truncated microtrichia. After washout, larvae remained immobile but excluded dye. The practical message is that movement, survival, surface structure, and reversibility are four separate questions, and this data set answers all four.

FAQ

What did the praziquantel protoscolex assay actually measure?

The assay measured two outcomes in parallel. Motility was scored from paired images taken 10 seconds apart at 40x, with pixel displacement expressed as a percentage of the solvent control. Viability was scored by methylene blue exclusion after 5 minutes at room temperature, with morphology checked as well. Protoscoleces came from cattle lung cysts and were exposed for 24 hours.

How potent was praziquantel against protoscolex motility?

In this praziquantel protoscolex experiment the 24-hour motility IC50 was 0.364 micromolar with a 95 percent interval of 0.0826 to 1.31 micromolar. The maximal effect reached 99.2 percent, with an R2 of 0.69. Amlodipine was more potent at 0.0207 micromolar, while amiloride was far weaker at 39.7 micromolar. Albendazole and cytochalasin D sat between them.

What IC50 and LC50 values were reported for praziquantel?

For motility the IC50 was 0.364 micromolar. For viability the LC50 was 2.51 millimolar with a 95 percent interval of 1.91 to 3.30 millimolar, and maximal viability loss was 83.4 percent. The lethal concentration therefore sat more than two orders of magnitude above the concentration that stopped movement. That gap is the central result of the praziquantel protoscolex testing.

Why did a single sigmoidal curve fail to fit the praziquantel data?

The compound dropped motility to an intermediate level and held there across several orders of magnitude before falling again at the top concentrations. A single sigmoidal curve cannot follow that shape. The four-parameter logistic fit showed significant lack of fit, with F(7,36) = 5.40 and p = 0.0003. A two-component model fit better, yet still left lack of fit at p = 0.02.

How did motility inhibition relate to viability loss?

Within each compound higher motility inhibition generally tracked lower viability. For praziquantel the Spearman coefficient was -0.98 with p = 0.002 after correction. Across all compounds the link weakened once dose was accounted for, with rs = -0.29 and a 95 percent interval spanning zero. Adding compound identity brought rs to 0.07, also not significant. Segmented models placed the breakpoint at 75.1 percent inhibition for ion-channel agents.

What did the washout experiment show about recovery?

Protoscoleces were washed after 24 hours and kept another 24 hours in drug-free medium. No compound produced a consistent or statistically supported return of motility. Five concentration combinations were dropped because post-washout viability fell below 15 percent. At 10^-4 M the praziquantel samples, along with albendazole and cytochalasin D, barely changed after washout while viability stayed between 78 and 95 percent.

How severe was tegument damage after praziquantel exposure?

Under scanning electron microscopy the praziquantel protoscolex specimens showed the most severe damage among the ion-channel agents. The tegument collapsed and often exposed the underlying syncytial layer. The rostellar pad was distorted, hooks were displaced or embedded in folded surface, and microtrichia were truncated or absent. Controls kept a continuous tegument densely covered by uniform microtrichia.

Which compound inhibited motility most strongly?

Amlodipine was the strongest motility inhibitor with an IC50 of 0.0207 micromolar and a maximal effect of 100.0 percent. Cytochalasin D followed at 0.0295 micromolar and praziquantel at 0.364 micromolar. Albendazole recorded 0.428 micromolar and amiloride was weakest at 39.7 micromolar. All five agents reduced movement in a concentration-dependent way.

What statistical methods were used to analyze the data?

Curves were fitted with a four-parameter logistic model with the top fixed at 100 percent. Absolute IC50 and LC50 were solved at 50 percent response. A two-component model was compared by AICc, and groups by Spearman rank correlation with partial correlation controlling dose and compound. Segmented regression found thresholds, and Holm-Bonferroni adjusted five tests per compound. Significance used p < 0.05.

How were protoscoleces cultured before dosing?

Protoscoleces were recovered under sterile conditions from intact cysts in cattle lungs. They were kept in DMEM with 0.4 percent glucose, 100 IU per milliliter penicillin and 100 microgram per milliliter streptomycin at 37 C in humidified 5 percent CO2. Cultures rested at least 24 hours before dosing. Wells were sterile 96-well flat-bottom plates holding 50 to 60 protoscoleces each.

What are the main limits of this in vitro model?

This is a plate assay on larval tissue, so it cannot show how a drug moves through a whole host. Motility scoring depends on image displacement and can miss immobile but viable worms. The intermediate plateau makes IC50 model-dependent, and lethal effects were only partly reached for some agents. Results apply to the tested concentration range of 10^-10 to 10^-2 M over 24 hours.